For Consumers

Based on the latest scientific knowledge, the Negen gene analysis covers an exceptionally broad range of genetic variants for different genes that affect the risk of disease. Our easy-to-understand report that combines lifestyle data to genetic data makes our test unique tool for health choice decision making.

Read more about Gene tests

Consulting

Our experts can consult with issues related to genotyping platforms, genetic variants, quality assurance, and the utilization of genetic data in healthcare and research.

Read more about consulting

Biobanks

Many Biobanks already has genotyped data or collected DNA, but the data's or DNA's full potential may not have been yet utilized. Cooperation between Negen and Biobanks enable the return of genetic health data for the sample donor in a cost-effective way.

Read about possibilities for Biobanks

Have you performed a genetic test for genealogy?

You can also use existing genetic information to perform a high quality Negen genome analysis!

Negen MyData 360 Negen MyData COVID-19

YOUR GENES, YOUR HABITS, YOUR HEALTH

Together, genes and lifestyle factors form a personal risk for contracting multifactorial diseases, which include diabetes and cardiovascular diseases. Analysing your personal genetic risk allows you to prevent the onset of these diseases as effectively as possible.

News

Negen opens a free COVID-19 pharmacogenomics panel

Negen opens a new pharmacogenomics panel. Panel focuses on pharmacogenomic effects of the medicines suggested for severe COVID-19 infection treatment. This panel is available free of charge for everyone having existing genome data from other sources, for example 23andMe and other ancestry services.

Read more

Negen to feature in HIMSS Europe 2019

This year, HIMSS Europe, the premier event in digital health, will be held in Finland (11.-13.6). Messukeskus Helsinki expects thousands of participants from around the world representing ministries, hospitals, and health technology companies.

More

Negen genomic analyses now available via Terveystalo

Finland’s largest health service provider Terveystalo maintains its role as pioneer by being the first to include Negen’s genomic tests in its offering.

Read More

Articles

Genomic testing provides the earliest indication of elevated disease risk

Early identification of disease risk enables effective prevention, which translates to more years of healthy living for the individual and significantly reduced healthcare costs.

Read More

Genetic risk assessment delivers measurable value to consumers

Are currently available genomic testing services reliable? And can they deliver real value? Here we attempt to answer both questions comprehensively.

Read More